Phase II Trial: uPAR PET/CT for Preoperative Staging of Breast Cancer Patients
Phase of Trial: Phase II
Latest Information Update: 14 Apr 2017
At a glance
- Drugs Gallium-68 NOTA AE105 (Primary)
- Indications Breast cancer
- Focus Diagnostic use
- 04 Apr 2017 Status changed from recruiting to completed.
- 09 Mar 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 18 Feb 2016 New trial record